C-Reactive Protein-Mediated Vascular Injury Requires Complement-Reference-Cited by-同舟云学术

C-Reactive Protein-Mediated Vascular Injury Requires Complement

Published:2010-06 Issue:6 Volume:30 Page:1189-1195
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:ATVB

Author:

Hage Fadi G.¹,Oparil Suzanne¹,Xing Dongqi¹,Chen Yiu-Fai¹,McCrory Mark A.¹,Szalai Alexander J.¹

Affiliation:

1. From the Vascular Biology and Hypertension Program, Division of Cardiovascular Disease (F.G.H., S.O., D.X., F.H., Y.-F.C.) and the Division of Clinical Immunology and Rheumatology (M.A.M., A.J.S.), Department of Medicine, The University of Alabama at Birmingham, and Section of Cardiology (F.G.H.), Birmingham Veteran’s Administration Medical Center, Birmingham, Ala.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference46 articles.

1. Exaggerated Neointima Formation in Human C-Reactive Protein Transgenic Mice Is IgG Fc Receptor Type I (FcγRI)-Dependent

2. Estrogen Treatment Abrogates Neointima Formation in Human C-Reactive Protein Transgenic Mice

3. C-Reactive Protein Binding to Murine Leukocytes Requires Fcγ Receptors

4. Structural recognition and functional activation of FcγR by innate pentraxins

5. Hage FG McCrory MA Szalai AJ. C-reactive protein and cardiovascular disease: Lessons learned from studying genetically engineered mice. In: Nagasawa S ed. C-Reactive Protein–New Research. Hauppauge NY: Nova Publishers; 2008: 83–116.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adipsin in the pathogenesis of cardiovascular diseases;Vascular Pharmacology;2024-03

2. Complement-pentraxins synergy: Navigating the immune battlefield and beyond;Biomedicine & Pharmacotherapy;2023-12

3. Vascular mechanotransduction;Physiological Reviews;2023-04-01

4. Recent advances into the role of pattern recognition receptors in transplantation;Cellular Immunology;2020-05

5. Current Position on the Role of Monomeric C-reactive Protein in Vascular Pathology and Atherothrombosis;Current Pharmaceutical Design;2020-02-25